Praxis Precision Medicines PRAX
NASDAQ PRAX
$300.65 +1.78 (+0.60%)
At close: Sep 22, 2026 · 4:00 PM EDT

Praxis Precision Medicines (PRAX) Common Equity (2019 - 2026)

Praxis Precision Medicines (PRAX) posted Common Equity of $1.3 billion for Q2 2026, down 4.89% on a QoQ basis from $1.4 billion in Q1 2026, and up 231.76% year-over-year from $404.2 million in Q2 2025.

Analysis

Praxis Precision Medicines (PRAX) Common Equity (2019 - 2026) Analysis & Trends

Praxis Precision Medicines has reported Common Equity for 8 years, with the latest figure at $1.3 billion in Q2 2026.

  • On a quarterly basis, Common Equity rose 231.76% year-over-year to $1.3 billion in Q2 2026; TTM through Jun 2026 was $1.3 billion, a 231.76% increase from a year earlier, with the FY2025 full-year figure at $878.1 million, up 97.13% from the prior year.
  • Common Equity was $1.3 billion for Q2 2026 at Praxis Precision Medicines, down from $1.4 billion in the prior quarter.
  • The five-year high for Common Equity was $1.4 billion in Q1 2026, with the low at $64.5 million in Q1 2023.
  • Average Common Equity over 5 years is $396.1 million, with a median of $286.6 million recorded in 2024.
  • The sharpest annual moves came in 2022 and 2024: Common Equity sank 69.66% in 2022, then soared 539.38% in 2024.
  • Over 5 years, Common Equity stood at $76.1 million in 2022, then dropped by 8.46% to $69.7 million in 2023, then jumped by 539.38% to $445.4 million in 2024, then soared by 97.13% to $878.1 million in 2025, then soared by 52.71% to $1.3 billion in 2026.
  • The last three Common Equity figures came in at $1.3 billion (Q2 2026), $1.4 billion (Q1 2026), and $878.1 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Amgen 212.54 Bn 198.55 Bn 7.24 Bn 11.69 Bn
2 Gilead Sciences 186.84 Bn 183.58 Bn 6.22 Bn 11.83 Bn
3 Vertex Pharmaceuticals 129.39 Bn 121.54 Bn 2.84 Bn 20.25 Bn
4 Regeneron Pharmaceuticals 82.05 Bn 74.06 Bn 3.93 Bn 31.71 Bn
5 Moderna 69.00 Bn 63.87 Bn 52.00 Mn 6.76 Bn
6 Argenx Se 61.15 Bn 55.97 Bn 1.37 Bn 8.42 Bn
7 Alnylam Pharmaceuticals 32.67 Bn 29.37 Bn 992.69 Mn 1.35 Bn
8 Biogen 32.37 Bn 31.08 Bn 1.96 Bn 18.85 Bn
9 Roivant Sciences 28.18 Bn 28.87 Bn 1.16 Mn 4.92 Bn
10 Praxis Precision Medicines 8.34 Bn 7.58 Bn - 1.34 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.34 Bn
Mar 31, 2026 1.41 Bn
Dec 31, 2025 878.14 Mn
Sep 30, 2025 343.51 Mn
Jun 30, 2025 404.22 Mn
Mar 31, 2025 439.21 Mn
Dec 31, 2024 445.45 Mn
Sep 30, 2024 382.67 Mn
Jun 30, 2024 419.10 Mn
Mar 31, 2024 229.68 Mn
Dec 31, 2023 69.67 Mn
Sep 30, 2023 86.76 Mn
Jun 30, 2023 105.63 Mn
Mar 31, 2023 64.47 Mn
Dec 31, 2022 76.11 Mn
Sep 30, 2022 105.16 Mn
Jun 30, 2022 138.87 Mn
Mar 31, 2022 191.02 Mn
Dec 31, 2021 250.81 Mn
Sep 30, 2021 295.92 Mn
API Access

Praxis Precision Medicines Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=PRAX&period=max&api_key=YOUR_API_KEY